Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death.

CINCINNATI, July 18 /PRNewswire-USNewswire/ — Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death. The researchers report in an upcoming edition of Nature Medicine that over-expression of the protein CIB1 (also called calmyrin) triggers biochemical …

Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death. The researchers report in an upcoming edition of Nature Medicine that over-expression of the protein CIB1 (also called calmyrin) triggers biochemical processes that lead to cardiac hypertrophy. The …

CAMBRIDGE, MA–(Marketwire – July 16, 2010) – Molecular Insight Pharmaceuticals, Inc. ( NASDAQ : MIPI ), a biopharmaceutical company discovering and developing targeted therapeutic and imaging radiopharmaceuticals for use in oncology, today announced that the Company has received a fifth extension of its waiver agreement with its Bond holders, allowing debt restructuring discussions to progress.

( University of Southern California ) The Keck School of Medicine of the University of Southern California (USC) has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone.

The Keck School of Medicine of the University of Southern California has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone. The multi-million dollar gift will support cancer research directed by renowned oncologist David Agus, M.D., professor of medicine at the Keck School of Medicine of USC and director of the USC Center for Applied Molecular …

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July18 – 22, 2010 in Philadelphia. AAPM is the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology.

CAMBRIDGE, MA–(Marketwire – 07/14/10) – Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI – News ) today announced that detailed results from a completed Phase 2 clinical trial of Zemiva (1) (Iodofiltic acid I 123) will be published in the July 20, 2010 edition of the Journal of the American College of Cardiology, which is now available online. Zemiva is a molecular imaging …

CAMBRIDGE, MA–(Marketwire – July 14, 2010) – Molecular Insight Pharmaceuticals, Inc. ( NASDAQ : MIPI ) today announced that detailed results from a completed Phase 2 clinical trial of ZemivaT 1 (Iodofiltic acid I 123) will be published in the July 20, 2010 edition of the Journal of the American College of Cardiology, which is now available online. Zemiva is a molecular imaging …

( University of Calgary ) Faculty of Medicine scientists have discovered a way to enhance nerve regeneration in the peripheral nervous system. This discovery could lead to new treatments for nerve damage caused by diabetes or traumatic injuries. Peripheral nerves connect the brain and spinal cord to the body, and without them, there is no movement or sensation. Peripheral nerve damage is common …

( BioMed Central ) Light has been cast on the interaction between broccoli consumption and reduced prostate cancer risk. Researchers writing in BioMed Central’s open-access journal Molecular Cancer have found that sulforaphane, a chemical found in broccoli, interacts with cells lacking a gene called PTEN to reduce the chances of prostate cancer developing.

Case Western Reserve University (CWRU) School of Medicine has won a $7.9 million grant from the National Institutes of Health to lead a malaria research team in Southeast Asia that aims to eradicate the disease. The CWRU medical school will lead 10 International Centers of Excellence for Malaria Research in the project to control malaria and [...]

When the University of Nevada, Reno’s $77 million Center for Molecular Medicine opens in September, it will house 40,000 mice and state-of-the-art laboratories to conduct research into possible cures for muscular dystrophy, breast cancer, stroke, herpes and Chronic Fatigue Syndrome and other illnesses.

The Rakyan lab is focused on understanding “epialleles” loci at which the epigenetic state varies as a result of stochastic, genetic and/or environmental influences.

The same molecular mechanism that increases life span through calorie restriction may help boost memory and brainpower, researchers at MIT’s Picower Institute for Learning and Memory report in the July 11 issue of Nature.

Moses Chao, PhD, professor of cell biology, physiology and neuroscience, and psychiatry at NYU School of Medicine, and a member of the Molecular Neurobiology Program at the Skirball Institute of Biomolecular Medicine, was named president-elect of the Society for Neuroscience (SfN), one of the largest organization of scientists and physicians devoted to advancing understanding of the brain and …

When the University of Nevada, Reno’s $77 million Center for Molecular Medicine opens in September, it will house 40,000 mice and state-of-the-art laboratories to conduct research into possible cures for muscular dystrophy, breast cancer, stroke, herpes and Chronic Fatigue Syndrome and other illnesses.

An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired by McMaster University professor Dr. Alexander Turpie…

Researchers from Mount Sinai School of Medicine have identified a previously unknown mechanism by which cells direct gene expression, the process by which information from a gene is used to direct the physical and behavioral development of individuals. The research, which may help scientists gain insight into how muscle and heart diseases develop, is published in the July 8th issue of Nature…

New Queen’s University research has shown that the growth of melanoma, one of the most deadly forms of skin cancer, can be slowed when a little known gene called MicroRNA 193b is added. Victor Tron, head of pathology and molecular medicine, focused on miR-193b when he discovered that it was deficient in melanoma tumors and because there were very few studies done about the gene. The miRNA-193b …